AK HB272

Health care insurers in Alaska may not charge higher copayments, deductibles, or coinsurance for patient-administered anti-cancer medications (oral or self-injected) than for provider-administered anti-cancer medications (injected or intravenously administered).

Insurers are prohibited from offsetting compliance costs by increasing out-of-pocket costs for provider-administered anti-cancer medications or reclassifying anti-cancer medication benefits.

"Anti-cancer medication" is defined as a drug or biologic used to kill cancerous cells or slow or prevent the growth of cancerous cells.

The law applies to health care insurers offering plans in Alaska but exempts fraternal benefit societies.

The requirement applies to all health insurance policies offered, issued, delivered, or renewed on or after the effective date of the act.